Skip to main content
. 2020 Nov 26;39(3):500–509. doi: 10.1016/j.clindermatol.2020.11.010

Table 3.

Impact of COVID-19 on dermatology practice: Survey questions and responses

Yes, n = (%) No, n = (%)
Do you continue to perform dermatologic procedures and biopsies? 71 (yes, but at limited capacity)
16 (yes, as before the outbreak)
13
Are you still using immunosuppressives to treat skin conditions? 68 (yes, but only for limited cases when highly indicated)
11 (yes, as before the outbreak)
21
Have you diagnosed one of the COVID-19 skin manifestations? 20 80
Due to COVID-19-related psychological upsets, do you notice an increase in the relapse rate of any chronic skin diseases? 51 49
Have you tried to switch immunosuppressives to more conservative options like topical agents/ phototherapy? 81 19
Have you acquired a COVID-19 infection during your work?
(PCR confirmed case only)
25 75
Do you provide online/phone consultations (teledermatology)? 72 28
Did you work at the respiratory triage or any other COVID-19-related unit? 19 81
Did you diagnose a case of measles during the current pandemic? 14 86